"There is value in the hope of achieving more than we expect."
Where I see patients (1)
My reviews
Selected research
-
Genome-wide association study identifies high-impact susceptibility loci for hepatocellular carcinoma in North America.
Hepatology (Baltimore, Md.)
-
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
The lancet. Gastroenterology & hepatology
-
Author Correction: Hepatocellular carcinoma.
Nature reviews. Disease primers
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 353-9888
4.9